On the afternoon of June 28, Wang Hainan, deputy director of the drug Registration Department of the State Drug Administration, Chen Yongmei, director of the licensing registry of the Anhui Drug Administration, Liu Baolei, deputy director of the registration Registry of the Yunnan Drug Administration, and Gao Yang, a director of the licensing registry of the Anhui Drug Administration, came to our hospital to investigate and guide the research and development of traditional Chinese medicine preparations. The Standing Committee of the University Party Committee and the secretary of the Party Committee of the hospital Nie Jiusheng, the president of the hospital Yang Wenming, the vice president Liu Jian, Wang Han and the heads of relevant departments attended the meeting.
At the meeting, Wang Hainan put forward optimization suggestions on compound Qiyi capsule and Gandouling tablet, the characteristic preparations of our hospital, from aspects of pharmaceutical resources, clinical observation, and drug users, and made clear the direction of research and development. He stressed that the development and innovation of traditional Chinese medicine and ethnic medicine preparations should combine traditional Chinese medicine theory, human experience and clinical trials, build a "three-combination" review evidence system that conforms to the characteristics of traditional Chinese medicine, and promote the development of traditional Chinese medicine and ethnic medicine preparations in medical institutions.
